WHC is still in active development. Read this to understand our approach.
depiction of AHOUBRCZNHFOSL-UHFFFAOYSA-N.svg
tripsit

paroxetine

Verificar en tripsit

isomerdesign

Paroxetine

Verificar en isomerdesign

pubchem

Paroxetine

Verificar en pubchem

drugmap

Paroxetine

Verificar en drugmap

wiki

Paroxetine

Verificar en wiki

Data

InChI: InChI=1S/C19H20FNO3/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18/h1-6,9,14,17,21H,7-8,10-12H2

Sinónimos: seroxat,(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)methyl)piperidine,piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, (3S,4R)-,Prestwick3_000851,DivK1c_006884,(3S,4R)-3-[(2H-1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine,NCGC00025355-02,Seroxat (TN),BRL-29060,Tox21_113123_1,Tox21_113123,NCGC00182968-01,PaxPar,AC-8185,Frosinor,Paxil CR,Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3S-trans)-,EN300-150199,Spectrum5_001665,NCGC00025355-05,NCGC00025355-07,BPBio1_000949,Paroxetinum [INN-Latin],SBI-0051908.P002,AB00053704-21,Paroxetine [USAN:INN:BAN],(3S,4R)-3-[(1,3-dioxaindan-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine,Parogen,NCGC00025355-03,KBio2_004800,32Q7TW8BX7,Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, trans-,(3s,4r)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine,AB00514724,paxil,Paroxetine, trans-(+/-)-,Paroxetine (TN),Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, trans-(+/-)-,CAS-61869-08-7,HSDB 7175,AKOS015888636,NCGC00025355-06,ZINC527386,(3S-trans)-3-[(1,3-Benzodioxol-5-yl-oxy)methyl]-4-(4-fluorophenyl)piperidine,KBio2_007368,Paroxetine I,Paxetil,CHEMBL490,(+/-)-Paroxetine,PAROXETINE [VANDF],BDBM50331515,HY-122272,SCHEMBL27799,(-)-TRANS-4-(P-FLUOROPHENYL)-3-((3,4-(METHYLENEDIOXY)PHENOXY)METHYL)PIPERIDINE,(3S,4R)-3-(Benzo[1,3]dioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine,paroxetine hydrochloride (anhydrous or hemihydrate),Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3S,4R)-,Spectrum_001752,KBio2_002232,SDCCGSBI-0051908.P003,110429-35-1,[3H]Paroxetine,PAROXETINE [WHO-DD],C07415,Paroxetina,NCGC00025355-22,KBio1_001828,(-)3s,4r-paroxetine,Paroxetinum,3h-paroxetine,Aropax,Paroxetine,BDBM22416,DSSTox_CID_3425,61869-08-7,Q408471,Rel-(3R,4S)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine,NNC-20-7051,Paxil,BRD-K37991163-050-05-1,Arotin,(-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]-piperidine,Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-,(3S,4R)-,Paroxetine II,Arketis,(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine,DB00715,Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, (3S-trans)-,(-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine,Piperidine,(3s,4R)-3-(Benzo[1,3]dioxol-5-yloxymethyl)-4-(4-fluorophenyl),Daparox,(3S,4R)-3-((1,3-BENZODIOXOL-5-YLOXY)METHYL)-4-(4-FLUOROPHENYL)PIPERIDINE,BRL 29060,FG 7051,CS-0083299,PAROXETINE [INN],cis-Paroxetine; Paroxetine USP Related Compound D;[(3S,4R)-4-(p-Fluorophenyl)-3-piperidyl](1,3-dioxa-5-indanyloxy)methane,BIDD:GT0673,PAROXETINE [USAN],41VRH5220H,(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine,NCGC00025355-04,HMS2090H05,130855-15-1,DSSTox_GSID_23425,8PR,Xetanor,PAROXETINE HCL HEMIHYDRATE,FG-7051,Paroxetine (USP/INN),KBioSS_002232,(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine,CHEBI:7936,BSPBio_000861,Motivan,Paroxetina [INN-Spanish],NCGC00025355-09,DSSTox_RID_77022,AB00053704_23,UNII-32Q7TW8BX7,PAROXETINE [MART.],Seroxat,Paroxetine.HCl,GTPL4790,Casbol,DTXSID3023425,PAROXETINE [MI],(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine,paroxetine,Paroxetine Hydrochloride Anhydrous EP Impurity E,UNII-41VRH5220H,(-)-Paroxetine,Paroxetine, (+/-)-,SpecPlus_000788,Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3R,4S)-rel-,AB00053704_22,D02362,NCGC00025355-12,CHEMBL1708,869P087,BRD-K37991163-003-02-7,NCGC00025355-08,Besitram

Estimated data

Solubilidad: -3.845 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 61.6% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.